Response to “iPTH is not a significant factor influencing the tacrolimus C/D ratio”-Reference-Cited by-同舟云学术

Response to “iPTH is not a significant factor influencing the tacrolimus C/D ratio”

Published:2022-02-19 Issue:4 Volume:15 Page:807-808
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Tanaka Ryota¹,Suzuki Yosuke²,Watanabe Hiroshi³,Fujioka Takashi⁴,Hirata Kenshiro⁵,Shin Toshitaka⁶,Ando Tadasuke⁶,Ono Hiroyuki¹,Tatsuta Ryosuke¹,Mimata Hiromitsu⁶,Maruyama Toru³,Itoh Hiroki¹

Affiliation:

1. Department of Clinical Pharmacy Oita University Hospital Yufu‐shi, Oita Japan

2. Department of Medication Use Analysis and Clinical Research Meiji Pharmaceutical University Kiyose, Tokyo Japan

3. Department of Biopharmaceutics Graduate School of Pharmaceutical Sciences Kumamoto University Kumamoto Japan

4. Laboratory of Medical Pharmaceutics Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Toyama Japan

5. Department of Clinical Pharmaceutics Faculty of Pharmaceutical Sciences Sojo University Kumamoto Japan

6. Department of Urology Faculty of Medicine Oita University Yufu‐shi, Oita Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13242

Reference6 articles.

1. Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end‐stage renal disease

2. Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule

3. Effects of Indoxylsulfate on the in vitro Hepatic Metabolism of Various Compounds Using Human Liver Microsomes and Hepatocytes

4. A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

5. Genetic African Ancestry and Markers of Mineral Metabolism in CKD